JPH0160035B2 - - Google Patents

Info

Publication number
JPH0160035B2
JPH0160035B2 JP57099456A JP9945682A JPH0160035B2 JP H0160035 B2 JPH0160035 B2 JP H0160035B2 JP 57099456 A JP57099456 A JP 57099456A JP 9945682 A JP9945682 A JP 9945682A JP H0160035 B2 JPH0160035 B2 JP H0160035B2
Authority
JP
Japan
Prior art keywords
compound
formula
compounds
group
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57099456A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57212196A (en
Inventor
Yunge Bodo
Myuraa Rutsutsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS57212196A publication Critical patent/JPS57212196A/ja
Publication of JPH0160035B2 publication Critical patent/JPH0160035B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
JP57099456A 1981-06-13 1982-06-11 Saturated aminocycritol derivative Granted JPS57212196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813123520 DE3123520A1 (de) 1981-06-13 1981-06-13 Gesaettigte aminocyclitderivate, ihre herstellung undsie enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
JPS57212196A JPS57212196A (en) 1982-12-27
JPH0160035B2 true JPH0160035B2 (en]) 1989-12-20

Family

ID=6134654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57099456A Granted JPS57212196A (en) 1981-06-13 1982-06-11 Saturated aminocycritol derivative

Country Status (14)

Country Link
US (1) US4536493A (en])
EP (1) EP0067356B1 (en])
JP (1) JPS57212196A (en])
AT (1) ATE11545T1 (en])
AU (1) AU8483382A (en])
CA (1) CA1216583A (en])
DE (2) DE3123520A1 (en])
DK (1) DK261482A (en])
ES (1) ES8305783A1 (en])
FI (1) FI71746C (en])
GR (1) GR81385B (en])
IL (1) IL66028A0 (en])
NO (1) NO821841L (en])
ZA (1) ZA824118B (en])

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
DE3543999A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Hochreine acarbose
IT1214708B (it) * 1986-08-01 1990-01-18 Medosan Ind Biochimi Impiego del dietilaminoetil-destrano (deae-d) come farmaco antidiabetico (diabete tipo i-ii-iii) e regolatore del metabolismo glucidico
FR2802817B1 (fr) * 1999-12-23 2002-10-11 Centre Nat Rech Scient Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
FR2917971B1 (fr) * 2007-06-28 2009-10-23 Engelhard Lyon Soc Par Actions Composition amincissante
CN101686918B (zh) * 2007-06-28 2014-05-21 巴斯夫美容护理法国公司 减肥组合物
US8153611B2 (en) 2007-06-28 2012-04-10 Basf Beauty Care Solutions France S.A.S. Use of sulfated oligosaccharides as slimming cosmetic ingredients
EP2145538A1 (de) 2008-07-15 2010-01-20 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Pflanzen- und Materialschutzmittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175123A (en) * 1976-12-23 1979-11-20 Bayer Aktiengesellschaft Amino-sugar derivatives, process for their preparation and pharmaceutical composition thereof
JPS5953920B2 (ja) * 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
JPS5643294A (en) * 1979-09-19 1981-04-21 Meiji Seika Kaisha Ltd Novel antibiotic sf-1130x substance, its preparation, and use
JPS5724397A (en) * 1980-07-21 1982-02-08 Meiji Seika Kaisha Ltd Amino sugar derivative substance having amylase inhibiting activity and its preparation

Also Published As

Publication number Publication date
ES513002A0 (es) 1983-03-16
FI71746C (fi) 1987-02-09
EP0067356B1 (de) 1985-01-30
FI822099A0 (fi) 1982-06-11
EP0067356A1 (de) 1982-12-22
NO821841L (no) 1982-12-14
FI71746B (fi) 1986-10-31
DE3123520A1 (de) 1982-12-30
JPS57212196A (en) 1982-12-27
DK261482A (da) 1982-12-14
AU8483382A (en) 1982-12-23
CA1216583A (en) 1987-01-13
US4536493A (en) 1985-08-20
GR81385B (en]) 1984-12-11
IL66028A0 (en) 1982-09-30
ATE11545T1 (de) 1985-02-15
ES8305783A1 (es) 1983-03-16
ZA824118B (en) 1983-04-27
DE3262124D1 (en) 1985-03-14

Similar Documents

Publication Publication Date Title
KR0181013B1 (ko) 결정질 2-오-알파-디-글루코피라노실-엘-아스코르브산을 함유시킨 화장품 조성물
US4408041A (en) Anhydrous crystals of maltitol and the whole crystalline hydrogenated starch hydrolysate mixture solid containing the crystals, and process for the production and uses thereof
US5863903A (en) Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
JP4128615B2 (ja) ピペリジン及びピロリジン
JPH02233610A (ja) 血管新生阻害剤
EP0455432B1 (en) Alpha-glycosyl naringin, and its preparation and uses
JPH037593A (ja) α―グリコシル　ヘスペリジンとその製造方法並びに用途
JPH0160035B2 (en])
JPS6152147B2 (en])
US5252722A (en) 5-O-α-D-glucopyranosyl-L-ascorbic acid
CN120040324A (zh) 一种根皮素衍生物及其制备治疗糖尿病的药物中的用途
US5272136A (en) 5-0-α-D-Glucopyranosyl-L-ascorbic acid, and its preparation and uses
US4035504A (en) Method for treating cholesterolemia by administering resorcylic acid lactone derivatives
JP3909735B2 (ja) マルトオリゴ糖誘導体及びその用途
JP2528083B2 (ja) カスタノスペルミンの単離法
WO2013172436A1 (ja) クロシンの新規糖付加化合物、その製造方法、及びその用途
JP2020188689A (ja) Ｔｏｘｉｃ ＡＧＥｓ生成抑制剤
JP2000044589A (ja) マルトオリゴ糖誘導体及びその用途
US3965275A (en) Composition and method
JP3194191B2 (ja) 組成物
KR101900594B1 (ko) 신규한 에르고스텐올 글리코시드 유도체
CN116473953B (zh) 咖啡酸甘油酯类化合物在制备药物或功能食品中的应用
JPS604129A (ja) 抗腫瘍剤
KR20250081156A (ko) L-세린 염산염의 제조 방법 및 이의 용도
JP2001233835A (ja) カルノジン酸誘導体およびそれを用いた神経成長因子合成促進剤